EcoR1 Capital, LLC's Form 4 filing
Voyager Therapeutics, Inc. (VYGR) · filed Jan 11, 2023
- Accession no.
- 0001567619-23-000839
- Filed
- Jan 11, 2023
- Trade date
- Jan 9-11, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $7.14M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| EcoR1 Capital, LLCCIK 0001587114 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | Common Stock | SSaleDisposed | −456,000 | $7.67 | −$3,497,520 | 4,297,907 | Indirect | |
| Jan 10, 2023 | Common Stock | SSaleDisposed | −336,400 | $8.05 | −$2,708,020 | 3,961,507 | Indirect | |
| Jan 11, 2023 | Common Stock | SSaleDisposed | −110,000 | $8.50 | −$935,000 | 3,851,507 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.